Bio-Path Holdings Inc (BPTH)
1.88
-0.15
(-7.39%)
USD |
NASDAQ |
May 28, 16:00
1.88
0.00 (0.00%)
After-Hours: 20:00
Bio-Path Holdings Free Cash Flow: -8.92M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.92M |
| December 31, 2023 | -11.54M |
| September 30, 2023 | -14.72M |
| June 30, 2023 | -15.31M |
| March 31, 2023 | -16.23M |
| December 31, 2022 | -15.12M |
| September 30, 2022 | -12.95M |
| June 30, 2022 | -12.46M |
| March 31, 2022 | -10.94M |
| December 31, 2021 | -9.987M |
| September 30, 2021 | -9.755M |
| June 30, 2021 | -9.217M |
| March 31, 2021 | -9.997M |
| December 31, 2020 | -10.96M |
| September 30, 2020 | -10.61M |
| June 30, 2020 | -10.15M |
| March 31, 2020 | -8.888M |
| December 31, 2019 | -8.361M |
| September 30, 2019 | -7.399M |
| June 30, 2019 | -6.977M |
| March 31, 2019 | -6.468M |
| December 31, 2018 | -6.141M |
| September 30, 2018 | -7.083M |
| June 30, 2018 | -7.141M |
| March 31, 2018 | -7.912M |
| Date | Value |
|---|---|
| December 31, 2017 | -8.495M |
| September 30, 2017 | -8.194M |
| June 30, 2017 | -8.597M |
| March 31, 2017 | -8.369M |
| December 31, 2016 | -8.486M |
| September 30, 2016 | -7.563M |
| June 30, 2016 | -6.856M |
| March 31, 2016 | -5.981M |
| December 31, 2015 | -5.005M |
| September 30, 2015 | -5.216M |
| June 30, 2015 | -5.076M |
| March 31, 2015 | -4.801M |
| December 31, 2014 | -3.94M |
| September 30, 2014 | -3.204M |
| June 30, 2014 | -2.834M |
| March 31, 2014 | -2.307M |
| December 31, 2013 | -2.313M |
| September 30, 2013 | -2.262M |
| June 30, 2013 | -2.087M |
| March 31, 2013 | -2.144M |
| December 31, 2012 | -2.018M |
| September 30, 2012 | -2.124M |
| June 30, 2012 | -1.961M |
| March 31, 2012 | -1.588M |
| December 31, 2011 | -1.32M |
Free Cash Flow Range, Past 5 Years
-16.23M
Minimum
Mar 2023
-6.977M
Maximum
Jun 2019
-11.03M
Average
-10.38M
Median
Free Cash Flow Benchmarks
| INVO Bioscience Inc | -4.362M |
| Perspective Therapeutics Inc | -23.28M |
| EyePoint Pharmaceuticals Inc | -16.65M |
| Palatin Technologies Inc | -33.83M |
| Lumos Pharma Inc | -34.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.038M |
| Cash from Financing (Quarterly) | 0.174M |
| Free Cash Flow Per Share (Quarterly) | -1.604 |
| Free Cash Flow Yield | -878.7% |